Verapamil Hci Injection, Solution
Product Images NDC 51662-1548

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Verapamil Hci (NDC 51662-1548). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Serialized Label (51662 1548 1 Serialized Vial Labeling)

FDA Label Image

Vial Label (51662 1548 1 Vial Labeling)

This is a medication label for an injection with the NDC code 55150-343-01. It is manufactured in India by AuroMedics Pharma LLC for S AV e TN [dR. The label states that it contains 10mg per 4mL (2.5mg/mL) and is for intravenous use only. The medication should be protected from light and comes in a single-dose vial.*

FDA Label Image

Adverse (Adverse)

This appears to be a list of potential adverse reactions and treatments for them, including symptomatic hypotension, bradycardia, AV block, and rapid ventricular rate. The document outlines various intravenous medications and supportive treatments that may be used depending on the severity of the clinical situation and the physician's judgment and experience.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.